MANAGEMENT OF ENDOCRINE DISEASE: Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MANAGEMENT OF ENDOCRINE DISEASE: Clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 170, Issue 4, Pages R121-R132
Publisher
Bioscientifica
Online
2014-01-16
DOI
10.1530/eje-13-1031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
- (2013) Marie Batisse et al. CANCER INVESTIGATION
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
- (2013) Thomas Cuny et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
- (2012) Giampaolo Trivellin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment
- (2012) Melanie Philippon et al. ANNALES D ENDOCRINOLOGIE
- Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10years? A critical view
- (2012) Alberto M. Pereira et al. ANNALES D ENDOCRINOLOGIE
- Subclinical hyperfunctioning pituitary adenomas: The silent tumors
- (2012) Odelia Cooper et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinicopathological Correlations in Pituitary Adenomas
- (2012) Ozgur Mete et al. BRAIN PATHOLOGY
- Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
- (2012) Aurélie Cornelius et al. BRAIN PATHOLOGY
- Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
- (2012) Gérald Raverot et al. CLINICAL ENDOCRINOLOGY
- Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas
- (2012) Cuong V Duong et al. ENDOCRINE-RELATED CANCER
- A classification tree approach for pituitary adenomas
- (2012) Alberto Righi et al. HUMAN PATHOLOGY
- Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1
- (2012) Daniela D'Angelo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas
- (2012) Nicholas F. Marko et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway
- (2012) T Palumbo et al. ONCOGENE
- Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
- (2012) Ilyess Zemmoura et al. Pituitary
- A miRNA Binding Site Single-Nucleotide Polymorphism in the 3′-UTR Region of the IL23R Gene Is Associated with Breast Cancer
- (2012) Lihong Wang et al. PLoS One
- Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
- (2011) Pornsuk Cheunsuchon et al. AMERICAN JOURNAL OF PATHOLOGY
- Treatment of pituitary neoplasms with temozolomide
- (2011) Gianluca Marucci CANCER
- Expression and function of ErbB receptors and ligands in the pituitary
- (2011) Odelia Cooper et al. ENDOCRINE-RELATED CANCER
- Identification of Growth Arrest and DNA-Damage-Inducible Gene β (GADD45β) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors
- (2011) Katherine A. Michaelis et al. ENDOCRINOLOGY
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course—Case Report and Review of the Literature
- (2011) Katarzyna Dudziak et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis
- (2011) D Palmieri et al. ONCOGENE
- Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas
- (2011) Lisiane Cervieri Mezzomo et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
- (2011) Ferdinand Roelfsema et al. Pituitary
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- Differential expression of microRNAs in GH-secreting pituitary adenomas
- (2010) Zhi-Gang Mao et al. Diagnostic Pathology
- Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis
- (2010) Françoise Galland et al. ENDOCRINE-RELATED CANCER
- Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
- (2010) Gérald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas
- (2010) Henriett Butz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The interperiosteo-dural concept applied to the perisellar compartment: a microanatomical and electron microscopic study
- (2010) Patrick François et al. JOURNAL OF NEUROSURGERY
- Atypical pituitary adenomas: incidence, clinical characteristics, and implications
- (2010) Gabriel Zada et al. JOURNAL OF NEUROSURGERY
- Proliferation markers of human pituitary tumors: Contribution of a genome-wide transcriptome approach
- (2010) Anne Wierinckx et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Isolation and characterization of novel pituitary tumor related genes: A cDNA representational difference approach
- (2010) Xun Zhang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy
- (2010) Hidenori Fukuoka et al. MOLECULAR ENDOCRINOLOGY
- MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas
- (2010) Henriett Butz et al. Pituitary
- Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
- (2010) Odelia Cooper et al. Hormones & Cancer
- Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients
- (2009) Jacqueline Trouillas et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
- (2009) Alexander Gorshtein et al. ENDOCRINE-RELATED CANCER
- Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
- (2009) D Dworakowska et al. ENDOCRINE-RELATED CANCER
- Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
- (2009) Marie-Lise Jaffrain-Rea et al. ENDOCRINE-RELATED CANCER
- Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
- (2009) Maria Chiara Zatelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
- (2009) Zhi Rong Qian et al. MODERN PATHOLOGY
- Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
- (2009) Marie S. Thearle et al. Pituitary
- Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands
- (2008) G. Vlotides et al. CANCER RESEARCH
- Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia
- (2008) X. Zhu et al. CLINICAL CANCER RESEARCH
- Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
- (2008) Ann I. McCormack et al. CLINICAL ENDOCRINOLOGY
- Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form
- (2008) Abdulkader Obari et al. ENDOCRINE PATHOLOGY
- Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
- (2008) Roger Gejman et al. HUMAN PATHOLOGY
- MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
- (2008) Fernando Colbari Amaral et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses
- (2008) Chheng-Orn Evans et al. Pituitary
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started